Ken Griffin Emergent Bio Solutions Inc. Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 281,501 shares of EBS stock, worth $2.51 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
281,501
Previous 20,300
1286.7%
Holding current value
$2.51 Million
Previous $98,000
1731.63%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding EBS
# of Institutions
188Shares Held
39.4MCall Options Held
299KPut Options Held
157K-
Black Rock Inc. New York, NY3.84MShares$34.2 Million0.0% of portfolio
-
Oak Hill Advisors LP New York, NY3.61MShares$32.2 Million2.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.58MShares$31.9 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.29MShares$20.4 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.85MShares$16.5 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $444M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...